Method for purifying urapidil with counter solvent recrystallization method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- HENAN FUREN MEDICAL TECH DEV
- Publication Date
- 2013-05-01
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for purifying uradil, in particular to a method for purifying uradil by using an anti-solvent recrystallization method, and belongs to the field of compound purification. Background technique
[0002] Urapidil (Urapidil) is uracil substituted by benzoxinazole, its chemical name is 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]-propyl]-amino] -1, 3-Dimethyl-2, 4(1H, 3H)-pyrimidinedione, the English name is 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1 ,3-dimethyl-2, 4(1H, 3H)-pyrimidinedione, the structural formula is:
[0003]
[0004] The trade names of urapidil hydrochloride are Ningding, Ebrantil and Lixidine. Its mechanism of action is 1 Receptor blockers and weaker β-receptor blockers have both peripheral and central hypotensive effects. Peripheral Major Blockade Alpha 1 receptor, and excitatory central 5-HT 1A Receptors, thereby reducing the sympathetic feedback regulation of the medullary cardiova...